Valuation: Alcon Inc.

Market Cap 32.52B 28.53B 26.34B 24.34B 46.13B 3,114B 47.05B 317B 123B 1,524B 122B 119B 5,290B P/E 2026 *
30.4x
P/E 2027 * 23.9x
Enterprise Value 35.12B 30.8B 28.44B 26.28B 49.81B 3,363B 50.81B 342B 133B 1,646B 132B 129B 5,712B EV / Sales 2026 *
3.15x
EV / Sales 2027 * 2.88x
Free-Float
97.36%
Yield 2026 *
0.53%
Yield 2027 * 0.61%
1 day+0.44%
1 week-1.84%
Current month-1.13%
1 month+0.67%
1 week 53.56
Extreme 53.56
55.84
1 month 51.38
Extreme 51.38
56.4
Current year 48.16
Extreme 48.16
56.4
1 year 48.16
Extreme 48.16
56.4
3 years 48.16
Extreme 48.16
56.4
5 years 48.16
Extreme 48.16
56.4
10 years 48.16
Extreme 48.16
56.4
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-1.84% - - 32.52B
+1.06%-2.57%-32.44%-0.09% 88.76B
+1.76%-4.73%-5.68%-26.25% 13.58B
+1.75%+2.93% - - 9.74B
-3.03%-0.19%-20.61%+498.47% 2B
-1.13%-3.66%-32.18%-66.11% 1.4B
0.00%+10.29%+27.99%+0.94% 897M
+1.38%+1.56%-39.02%-27.99% 836M
-2.31%-0.06%+43.03%-31.49% 771M
-1.42%+6.01% - - 684M
Average -0.19%+0.12%-8.42%+49.64% 13.19B
Weighted average by Cap. +0.81%-1.82%-27.88%+4.58%

Financials

2026 *2027 *
Net sales 11.14B 9.77B 9.02B 8.34B 15.8B 1,067B 16.12B 108B 42.13B 522B 41.83B 40.91B 1,812B 11.82B 10.37B 9.57B 8.84B 16.76B 1,132B 17.1B 115B 44.7B 554B 44.38B 43.41B 1,922B
Net income 1.12B 982M 906M 838M 1.59B 107B 1.62B 10.9B 4.23B 52.45B 4.2B 4.11B 182B 1.38B 1.21B 1.12B 1.04B 1.96B 133B 2B 13.48B 5.24B 64.87B 5.2B 5.09B 225B
Net Debt 2.6B 2.28B 2.1B 1.94B 3.68B 249B 3.76B 25.27B 9.82B 122B 9.75B 9.53B 422B 1.54B 1.35B 1.25B 1.15B 2.19B 148B 2.23B 15B 5.83B 72.2B 5.79B 5.66B 251B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
09/07/26 CHF 54.32 +0.37% 142,384
08/07/26 CHF 54.12 -0.92% 150,000
07/07/26 CHF 54.62 -0.98% 100,000
06/07/26 CHF 55.16 -0.47% 100,000
03/07/26 CHF 55.42 +0.07% 100,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
66.69USD
Average target price
95.06USD
Spread / Average Target
+42.56%

Quarterly revenue - Rate of surprise